LEI 549300K41J0H2MENQU80

JANSSEN VACCINES & PREVENTION B.V.

Group parent: Johnson & JohnsonJNJ · UN

Awards tracked

15

Value

€1.11M

Countries

NL

Download sample CSV

Contract awards & public grants

FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE → JANSSEN VACCINES & PREVENTION BV

European Commission · NL · Grant · 2026-06-02

—

Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research → JANSSEN VACCINES & PREVENTION BV

European Commission · NL · Grant · 2024-07-26

—

Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance → JANSSEN VACCINES & PREVENTION BV

European Commission · NL · Grant · 2023-05-10

—

Intelligent design of adenovirus vectors (iAds) → JANSSEN VACCINES & PREVENTION BV

European Commission · NL · Grant · 2022-12-20

€531,169

Experimental vaccinology, revealing unnatural signatures of protection by repeat controlled human schistosome infection. → JANSSEN VACCINES & PREVENTION BV

European Commission · NL · Grant · 2022-05-10

—

Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance → JANSSEN VACCINES & PREVENTION BV

European Commission · NL · Grant · 2021-11-09

—

INnate-ImmunomeTabolIsm as Antiviral TargEt → JANSSEN VACCINES & PREVENTION BV

European Commission · NL · Grant · 2019-05-21

€265,620

Vaccines and Infectious Diseases in the Ageing PopuLation → JANSSEN VACCINES & PREVENTION BV

European Commission · NL · Grant · 2018-12-10

—

Bringing a prophylactic Ebola vaccine to licensure → JANSSEN VACCINES & PREVENTION BV

European Commission · NL · Grant · 2018-06-15

—

Optimizing a deployable high efficacy malaria vaccine → JANSSEN VACCINES & PREVENTION BV

European Commission · NL · Grant · 2016-12-09

€25,000

Training network providing cutting-EDGE knowlEDGE on Herpes Virology and Immunology → JANSSEN VACCINES & PREVENTION BV

European Commission · NL · Grant · 2016-04-05

€255,374

European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates → JANSSEN VACCINES & PREVENTION BV

European Commission · NL · Grant · 2015-12-17

€34,845

Manufacturing and Development for Rapid Access Ebola Vaccine (EBOMAN) – Sofia ref.: 115850 → JANSSEN VACCINES & PREVENTION BV

European Commission · NL · Grant · 2015-03-06

—

Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II - Sofia ref.: 115861 → JANSSEN VACCINES & PREVENTION BV

European Commission · NL · Grant · 2015-03-06

—

Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen – Sofia ref.: 115854 → JANSSEN VACCINES & PREVENTION BV

European Commission · NL · Grant · 2015-03-05

—

Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.